A prospective observational study to evaluate a possible relationship between vitamin K antagonist therapy and risk of peripheral arterial disease in patients with type 2 diabetes.
Olivier BourronKamel MohammediJoe De KeizerFabrice SchneiderSamy HadjadjPierre-Jean SaulnierPublished in: Diabetes, obesity & metabolism (2024)
In this prospective study, we did not observe any excess risk of PAD requiring lower-limb revascularization in people with type 2 diabetes using VKAs. However, our data suggest a high risk of LLA in VKA users. Further studies are required to confirm this observation.